First Horizon Corporation’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36K Hold
409
– – ﹤0.01% 744
2026
Q2
$39.9K Buy
409
+26
+7% +$2.27K ﹤0.01% 760
2026
Q1
$32.1K Buy
+383
New +$22.2K ﹤0.01% 763

Other funds holding DNTH

First Horizon Corporation's DNTH Position: Q3 2026 in Review

First Horizon Corporation held its Dianthus Therapeutics (DNTH) position steady in Q3 2026 at 409 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

First Horizon Corporation first reported a position in DNTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $39.9K in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • First Horizon Corporation held 409 shares of Dianthus Therapeutics worth $36K as of Q3 2026.
  • First Horizon Corporation left its Dianthus Therapeutics share count unchanged in Q3 2026.
  • Dianthus Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q3 2026, its #744 holding.
  • First Horizon Corporation first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • First Horizon Corporation's Dianthus Therapeutics position peaked at $39.9K in Q2 2026.
  • 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on First Horizon Corporation's 13F filing for Q3 2026, filed 26 Oct 2026.